feedback welcome


From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][checked revision]
Line 9: Line 9:
| info =  
| info =  
* {{theorSS}}
* {{theorSS}}
* Fluoxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. }}
* Fluoxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine.  
<ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref> }}

Current revision as of 14:05, 4 November 2015

Type Antidepressant
Group SMS
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine
Type Antidepressant
Group SSRI
Medscape Fluoxetine
PubChem 3386
PubMed Fluoxetine
Kompas (Dutch) Fluoxetine
Wikipedia Fluoxetine

Switch medication from vortioxetine to fluoxetine.

Nietinrijdenbord.png Stop vortioxetine
Eenrichtingbord.png Start fluoxetine
Infobord.png More information

[1] [2]

The editors of take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.